Cargando…

Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination

We recently reported that sub-acute myocarditis occurred following the initial two doses of messenger RNA-based vaccination against coronavirus disease 2019 (0.3 mL Comirnaty(®)) in elderly Japanese patients with cardiac dysfunction. The present retrospective study of 76 patients revealed that myoca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyazaki, Koji, Fujii, Toshiharu, Mori, Kikue, Tamimoto, Ryuichi, Nagamatsu, Hirofumi, Murakami, Tsutomu, Cho, Yasunori, Goto, Shinya, Mori, Hidezo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961568/ https://www.ncbi.nlm.nih.gov/pubmed/36835957 http://dx.doi.org/10.3390/jcm12041421

Ejemplares similares

Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
por: Fujii, Masayoshi, et al.
Publicado: (2023)

A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients
por: Naveed, Zaeema, et al.
Publicado: (2023)

Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series
por: Murakami, Yoshiki, et al.
Publicado: (2021)

Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine
por: Wang, Mingwei, et al.
Publicado: (2022)

Incidence of Myocarditis after Messenger RNA Vaccine for COVID-19 in Young Male Recipients
por: Kato, Shingo, et al.
Publicado: (2022)

Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022)

Imaging of Myocarditis Following mRNA COVID-19 Booster Vaccination
por: Sanchez Tijmes, Felipe, et al.
Publicado: (2022)

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
por: Le Vu, Stéphane, et al.
Publicado: (2022)

Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults
por: Florea, Ana, et al.
Publicado: (2022)

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
por: Su, Wei-Ju, et al.
Publicado: (2023)

A PATCHY CONUNDRUM: A CASE OF MYOCARDITIS POST COVID-19 BOOSTER VACCINATION
por: Jordan, Timothy, et al.
Publicado: (2023)

This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 messenger RNA booster dose vaccination
por: Kantor, Jonathan
Publicado: (2022)

Severe Acute Myocarditis after the Third (Booster) Dose of mRNA COVID-19 Vaccination
por: Mengesha, Bethlehem, et al.
Publicado: (2022)

Impact of various vaccine boosters on neutralization against omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine
por: Huang, Qingrui, et al.
Publicado: (2022)

Overlapping Myocarditis and Postural Orthostatic Tachycardia Syndrome After COVID-19 Messenger RNA Vaccination: A Case Report
por: Sanada, Yuichi, et al.
Publicado: (2022)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile
por: Acevedo, Johanna, et al.
Publicado: (2023)

Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis – A Systematic Review of Population-Based Data
por: Lin, Yen-Ching, et al.
Publicado: (2023)

T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents
por: Schiavoni, Ilaria, et al.
Publicado: (2023)

Immunogenicity and Reactogenicity of Messenger RNA Coronavirus Disease 2019 Vaccine Booster Administered by Intradermal or Intramuscular Route in Thai Older Adults
por: Assantachai, Prasert, et al.
Publicado: (2023)

Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022)

Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine
por: Mori, Masahiko, et al.
Publicado: (2023)

HIV and Messenger RNA (mRNA) Vaccine
por: Khalid, Khizer, et al.
Publicado: (2021)

Systemic Lupus Induced by Messenger RNA Vaccination
por: Voisin, Olivier, et al.
Publicado: (2022)

Framing vaccine mandates: messenger and message effects
por: Buccafusco, Christopher, et al.
Publicado: (2022)

Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan
por: YAMANAKA, Takashi, et al.
Publicado: (2017)

Booster Vaccination: The Role of Reduced Antigen Content Vaccines as a Preschool Booster
por: Gabutti, Giovanni, et al.
Publicado: (2014)

Messenger RNA vaccines and neutralizing anti–severe acute respiratory syndrome coronavirus 2 antibodies in patients with immunodeficiency
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection
por: Gaebler, Christian, et al.
Publicado: (2022)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak
por: Ren, Zhenxiao, et al.
Publicado: (2022)

A Case Series of Myocarditis Following Third (Booster) Dose of COVID-19 Vaccination: Magnetic Resonance Imaging Study
por: Shiyovich, Arthur, et al.
Publicado: (2022)

Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation
por: Lim, Yongwhan, et al.
Publicado: (2021)

Temporary exacerbation of pre-existing psoriasis and eczema in the context of COVID-19 messenger RNA booster vaccination: A case report and review of the literature
por: Phuan, Crystal Zhen Yu, et al.
Publicado: (2021)

COVID-19 Vaccine and Myocarditis
por: Salah, Husam M., et al.
Publicado: (2021)

COVID-19 vaccines and myocarditis
por: Kerneis, Mathieu, et al.
Publicado: (2021)

Myocarditis following Coronavirus vaccination
por: Ferchichi, Khouloud, et al.
Publicado: (2022)

Antipyretics and vaccine‐induced myocarditis
por: Hoption Cann, Stephen A.
Publicado: (2023)

Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bsk3st4kpk3pqmbo42uvl5tt2d